Dawnrays Pharmaceutical Holdings Ltd.(HK:2348)
HK$0.88-0.01 (-0.56%)
HK:2348
Dawnrays Pharmaceutical Holdings Ltd. financials statements
HK$0.88
At close:-0.01 (-0.56%)
Want to see HK:2348 full AI Analyst Report?
Dawnrays Pharmaceutical Holdings Ltd. (2348) Income Statement
6 Followers
Dawnrays Pharmaceutical Holdings Ltd. Income Statement
Last quarter (Q2 2026), Dawnrays Pharmaceutical Holdings Ltd.'s total revenue was ¥538.31M, a decrease of 6.78% from the same quarter last year. In Q2, Dawnrays Pharmaceutical Holdings Ltd.'s net income was ¥121.64M. See Dawnrays Pharmaceutical Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 1.23B | ¥ 1.06B | ¥ 1.15B | ¥ 1.28B | ¥ 1.17B | |
| ¥ 557.40M | ¥ 577.63M | ¥ 641.52M | ¥ 766.68M | ¥ 675.36M | |
| ¥ 327.75M | ¥ 209.72M | ¥ 199.20M | ¥ 344.27M | ¥ 293.47M | |
| Depreciation and Amortization | ¥ 120.15M | ¥ 106.62M | ¥ 83.89M | ¥ 66.41M | ¥ 57.55M |
| ¥ 347.57M | ¥ 308.67M | ¥ 498.94M | ¥ 505.19M | ¥ 438.31M | |
| ¥ 229.65M | ¥ 367.91M | ¥ 277.42M | ¥ 422.41M | ¥ 380.76M | |
| ¥ 19.96M | ¥ 269.04M | ¥ 136.64M | ¥ 16.00M | ¥ 57.43M | |
| ¥ 249.61M | ¥ 636.95M | ¥ 414.06M | ¥ 438.41M | ¥ 439.32M | |
| ¥ 213.97M | ¥ 564.94M | ¥ 326.00M | ¥ 358.06M | ¥ 358.18M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 0.14 | ¥ 0.38 | ¥ 0.22 | ¥ 0.24 | ¥ 0.24 |
| Diluted EPS | ¥ 0.14 | ¥ 0.38 | ¥ 0.22 | ¥ 0.24 | ¥ 0.24 |
| Weighted Average Shares Outstanding | 1.50B | 1.51B | 1.50B | 1.50B | 1.50B |
| Weighted Average Shares Outstanding (Diluted) | 1.50B | 1.51B | 1.50B | 1.50B | 1.51B |
Currency in CNY

